Atlas Trials

ALIMTA (Pemetrexed) in Patients With Locally Advanced or Metastatic Cancer

Clinical trial NCT00034463 · COMPLETED

Trial details

NCT number
NCT00034463
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
MetastasesCancer

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.